Dear President Elect Trump, An important issue that needs your attention:

Hello President Elect Trump,

In September 2016, The DEA sought to place an emergency scheduling on Mitragyna Speciosa (Kratom).  An act that not only creates major border issues but also creates issues for the many people who utilize this plant as a form of herbal medicine.

At present, Dec. 4, 2016, the DEA has been forced to accept public comment by massive outcry, a protest was launched at whitehouse.gov website and in Washington DC.  Public comments were accepted until 12/1/16, and over 22,000 people commented at over 99 percent in favor of keeping Mitragyna Speciosa legal and unscheduled by the DEA

I bring to your attention the following article written on September 8th, by the CRE:
http://www.thecre.com/forum8/wp-content/uploads/2016/09/CRE-DEA-Kratom-1.pdf
Because Kratom is LEGAL in Canada (and Mexico), outlawing it in the US creates a potentially multi billion dollar issue for our great country, to quote the CRE: "DEA’s Action on Kratom Violates the US-Canada Regulatory Cooperation Council (RCC) Agreement"
Canada considers Mitragyna Speciosa to be a "beneficial herb"  Illegalizing it in the US would put it in the hands of dangerous drug smugglers in Mexico and Canada.  Instead of being legally imported it would change to being illegally smuggled.  I'm sure there is more here than meets the eye.

I bring to your attention that much medical study has been done on this plant, that shows it to be a potential safe replacement for Opioids, in a time where America is in crisis over Opioid addictions, Mitragyna Speciosa can potentially save many lives if allowed to continue being legal for the people and the scientists.  Largely due to the profits such Opioid addiction gives to the pharmaceutical industry, the DEA/FDA support making this plant a schedule 1...yet their drugs kill over 20,000 patients a year on average, many of whom turn to street drugs in desperation after being cut off of their pain meds.  Kratom helps people avoid such life threatening addictions to Opioids when searching for pain relief.  Keeping Kratom from the people makes no sense!
Columbia University Study by Andrew Kruegel et al: https://d3n8a8pro7vhmx.cloudfront.net/americankratomassociation/pages/21/attachments/original/1467415534/Journal_Of_The_American_Chemical_Society_6-6-16_Report.pdf?1467415534

**PLEASE NOTE:  Kratom has been used for various ailments in Asia & Chinese Medicine for over 1000 years.

Finally Sir, I bring to your attention, a response to the DEA's desire to schedule Mitragyna Speciosa (Kratom), which answers to the lies the DEA stated in order to schedule the plant.  This was put together in conglomeration by Pinney Associates and the Kratom Community.  This document provides valid proof of research in the medical world as well as expresses the data proving that Kratom alone has killed ZERO people while Opioids have killed hundreds of thousands.  Kratom is an effective herbal alternative that helps many people who would otherwise live in extreme pain to be positive contributing members of society.
https://drive.google.com/file/d/0B_SMhCuwVcKjeFRMVjlGMk5PM2M/view 


Some theorize that the DEA would like to profit more from the illegal drug trade, and Kratom is blocking their path. NDNR writer Jillian Stansbury states: "Prescriptions for opiate-based analgesics have skyrocketed in the last decade, according to DEA statistics,²which many people report is an inciting factor that ultimately leads to heroin addiction. The opiate industry itself is almost nothing but dark – troubled by the limited availability of raw material, low yields, and the byproduct of toxic wastes, in addition to the addiction, associated crime, and high mortality and morbidity.³ Furthermore, an attempt to gain access to poppy raw materials the United States may be a hidden agenda in the US efforts to muscle its presence into Afghanistan. Canadian economics professor, Michel Chossudovsky, reported that “Heroin is a multibillion dollar business supported by powerful interests, which requires a steady and secure commodity flow. One of the “hidden” objectives of the war [in Afghanistan] was precisely to restore the CIA sponsored drug trade to its historical levels and exert direct control over the drug routes.” ⁴ Full article here:  http://ndnr.com/autoimmuneallergy-medicine/opiate-addiction/

PLEASE READ!  I will kindly provide you with any additional information you would like.  
Sincerely,
Melody Page
Lake Worth, FL

Big pharma is paying someone... follow the corruption trail... Kratom is eating their profits by un-hooking Opiate addiction

Follow the trail... who signed off on the intent to schedule is who is getting paid.  The next time you vote... remember to NOT VOTE for those who you know are corrupt and care more about the payoffs they are getting than the people they are supposed to be serving.  The truth is in this document.  Our own United States Secretary of Health, ignored the scientific studies and quietly signed off on the DEA's request, without requiring any data... why?  $$$ Public servant, I think not.

DEA Admits Kratom has medical value! A step forward...

https://www.washingtonpost.com/news/wonk/wp/2016/09/15/the-dea-wants-to-ban-another-plant-researchers-say-the-plan-is-insane/

Melvin Patterson is quoted in the article as saying:

"I don't see it being Schedule 2 [or higher] because that would be a drug that's highly addictive," he said. "Kratom's at a point where it needs to be recognized as medicine. I think that we are going to find out that probably  it does."

He cautioned that research would be necessary to know for sure how to best regulate the drug, and it's safest to put kratom on Schedule 1 in the meantime. Still, Patterson noted that public response to the ban has been overwhelming.

"That was eye-opening for me personally," he said. "I want the kratom community to know that the DEA does hear them. Our goal is to make sure this is available to all of them.".

J.A.C.S Full report on the medical benefits of Mitragyna Spinosa

https://d3n8a8pro7vhmx.cloudfront.net/americankratomassociation/pages/21/attachments/original/1467415534/Journal_Of_The_American_Chemical_Society_6-6-16_Report.pdf?1467415534
Clip from Article:
ABSTRACT: Mu-opioid receptor agonists represent mainstays of pain management. However, the therapeutic use of these agents is associated with serious side effects, including potentially lethal respiratory depression. Accordingly, there is a longstanding interest in the development of new opioid analgesics with improved therapeutic profiles. The alkaloids of the Southeast Asian plant Mitragyna speciosa, represented by the prototypical member mitragynine, are an unusual class of opioid receptor modulators with distinct pharmacological properties. Here we describe the first receptor-level functional characterization of mitragynine and related natural alkaloids at the human mu-, kappa-, and delta-opioid receptors. These results show that mitragynine and the oxidized analogue 7-hydroxymitragynine, are partial agonists of the human mu-opioid receptor and competitive antagonists at the kappa- and delta-opioid receptors. We also show that mitragynine and 7-hydroxymitragynine are G-protein-biased agonists of the mu-opioid receptor, which do not recruit β-arrestin following receptor activation. Therefore, the Mitragyna alkaloid scaffold represents a novel framework for the development of functionally biased opioid modulators, which may exhibit improved therapeutic profiles. Also presented is an enantioselective total synthesis of both (−)-mitragynine and its unnatural enantiomer, (+)-mitragynine, employing a proline-catalyzed Mannich−Michael reaction sequence as the key transformation. Pharmacological evaluation of (+)-mitragynine revealed its much weaker opioid activity. Likewise, the intermediates and chemical transformations developed in the total synthesis allowed the elucidation of previously unexplored structure−activity relationships (SAR) within the Mitragyna scaffold. Molecular docking studies, in combination with the observed chemical SAR, suggest that Mitragyna alkaloids adopt a binding pose at the mu-opioid receptor that is distinct from that of classical opioids.

Columbia University NY Published study on Kratom from May 2016

http://pubs.acs.org/doi/abs/10.1021/jacs.6b00360 Published in May 2016. Laboratory results from Columbia University in NY on Kratom, show that the plant works for Opioid Receptors in a way that is distinct from classical Opioids.

Marajuana Advocacy Groups Give Support to the Kratom Community

I always love it when positive forces combine.  People supporting people.  Great energy here!  The Drug Policy Alliance supports Kratom.  Article here:  http://www.weednews.co/help-the-drug-policy-alliance-stop-the-deas-war-on-kratom/

Libertarians vote for Kratom to stay as it is... a natural, beneficial herb

While the American people are demanding drug peace and self-ownership, the DEA is headed in the wrong direction with kratom. written by Libertarian National Committee Chair, Nicholas Sawark
https://www.lp.org/news/press-releases/lnc-chairs-comments-on-dea-scheduling-of-kratom-like-heroin?utm_source=iContact&utm_medium=email&utm_campaign=Libertarian+Party&utm_content=20160907+GENPR+kratom

I wrote to Presidential candidate Gary Johnson about this issue.  Maybe he heard me? Thanks Libertarians!  God Love You!